SEC Filing Summary

Anthony Hunt, a director at BIOLIFE SOLUTIONS INC (BLFS), reported the disposition of 15,046 shares of common stock on October 6, 2026. This transaction occurred in connection with the merger of Bravo Merger Sub I, Inc. with and into BioLife Solutions, Inc. following an agreement with Repligen Corporation. Each outstanding share of common stock was converted into $11.25 in cash and 0.1442 shares of Repligen common stock. This disposition resulted in zero shares held post-transaction. The filing is Form 4, indicating a change in beneficial ownership. The transaction code